Original filing (PDF)20250718203532NAL0001191011001

APRECIA PHARMACEUTICALS, LLC

Name: APRECIA PHARMACEUTICALS, LLC — APRECIA PHARMACEUTICALS 401(K) PLAN, Form 5500 (2024)
Creator: APRECIA PHARMACEUTICALS, LLC

Form 5500-SF

FILING_RECEIVED

APRECIA PHARMACEUTICALS 401(K) PLAN

401(k) retirement plan

Active participants

Accounts w/ balance

Plan assets (EOY)

$7.3M

Net assets (EOY)

$7.3M

Plan health score (directional)

/ 100

Grade A

Top-tier plan health

Directional indicator computed from public Form 5500 data — compliance, concentration, cost, vendor stack and participation. Not a fiduciary tool.

Compliance & disclosures

100

Concentration risk

Total plan cost

Vendor stack

100

Participation health

Decision-maker contacts

CFO / Head of HR / Benefits Manager — verified email + LinkedIn for APRECIA PHARMACEUTICALS, LLC.

Plan sponsor

Name

APRECIA PHARMACEUTICALS, LLC

EIN

61-1852066

Address

7200 INDUSTRIAL ROW DRIVE · SUITE 200 · MASON, OH · 45040

Phone

(513) 984-5000

Industry

Wholesale Tradesee all

Plan administrator

Same as plan sponsor.

Plan characteristics

Plan number

001

Plan year

2024

Plan year begin

2024-01-01

Tax period

2024-12-31

Filed

2025-07-18

Pension benefit codes

2A · Age/service weighted or new comparability

2E · Profit-sharing

2F · ERISA section 404(c)

2G · Total participant-directed accounts

2J · 401(k) feature

2K · 401(m) arrangement

2R · Participant-directed brokerage (SDBA)

2T · Default investment account (QDIA)

Service providers (Schedule C)

Small plans don't disclose service providers

Related plans

Similar-size Wholesale Trade plans

DIVERSIFIED SALES COMPANY

DIVERSIFIED SALES COMPANY 401(K) PLAN

$7.5M · 56 participants

AMPAK COMPANY, INC.

AMPAK COMPANY, INC. 401(K) PROFIT SHARING PLAN

$7.0M · 29 participants

TORRENT PHARMA INC

TPI DEFINED CONTRIBUTION PLAN

$7.6M · 30 participants

FLAVINE NORTH AMERICA, INC.

FLAVINE NORTH AMERICA, INC. 401(K) PLAN

$7.6M · 18 participants

GERITOM MED INC.

GERITOM MED INC. 401(K) PLAN AND TRUST

$7.0M · 103 participants